Summary
This 8-K Amendment from HCA Healthcare, Inc. (HCA) provides crucial updates on the compensation package for its newly appointed Executive Vice President and Chief Operating Officer, Jon M. Foster. While the initial appointment was announced in October 2022, this filing details material changes to Mr. Foster's compensation, approved by the Compensation Committee in January 2023. The key changes include an increase in base salary and a significant long-term equity incentive award, signaling the company's investment in key executive talent for its operational leadership. Investors should note the details of Mr. Foster's enhanced compensation, which includes a base salary adjustment to $1,000,000 and a substantial equity grant valued at $3,750,000. This equity award is structured with a mix of stock appreciation rights and performance share units, aligning a significant portion of his compensation with long-term company performance and shareholder value. This filing clarifies compensation details that were undetermined at the time of the initial appointment announcement.
Key Highlights
- 1HCA Healthcare amends a previous 8-K filing to disclose updated executive compensation for COO Jon M. Foster.
- 2Mr. Foster's base salary increased to $1,000,000 effective January 1, 2023.
- 3A long-term equity incentive award of $3,750,000 was granted to Mr. Foster.
- 4The equity award consists of 50% stock appreciation rights vesting over four years.
- 5The other 50% of the equity award is in the form of performance share units tied to a three-year cumulative earnings per share goal.
- 6These compensation changes were approved by the Compensation Committee on January 24, 2023.
- 7This amendment provides details previously undetermined at the time of Mr. Foster's initial appointment announcement.